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Abstract 
Clinically established thermal therapies like thermo ablative approaches or adjuvant 
hyperthermia treatment rely on accurate thermal dose information for the evaluation and 
adaptation of the thermal therapy. Intratumoral temperature measurements have been 
correlated successfully with clinical endpoints. Magnetic resonance imaging is the most 
suitable technique for non-invasive thermometry avoiding complications related to invasive 
temperature measurements. Since the advent of MR thermometry two decades ago, 
numerous MR thermometry techniques have been developed continuously increasing 
accuracy and robustness for in vivo applications. While this progress was primarily focused on 
relative temperature mapping, current and future efforts will likely close the gap towards 
quantitative temperature readings. These efforts are essential to benchmark thermal therapy 
efficiency, understand temperature related biophysical and physiological processes and to 
use these insights to set new landmarks for diagnostic and therapeutic applications. With that 
in mind, this review summarizes and discusses advances in MR thermometry providing 
practical considerations, pitfalls and technical obstacles constraining temperature 
measurement accuracy, spatial and temporal resolution in vivo. Established approaches and 
current trends in thermal therapy hardware are surveyed with respect to potential benefits for 
MR thermometry. 
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Background 
Thermal therapies can be classified into two groups: (i) thermo ablative approaches with 
tissue temperatures above 50°C and hyperthermia covering tissue temperatures of 40-45°C. 
Invasive methods for thermal ablation include laser induced thermal therapy (LITT), radio 
frequency (RF) ablation or cryoablation (1, 2). Non-invasive thermo-ablative approaches 
involve high-intensity focused ultrasound (HIFU). Magnetic resonance (MR) guided focused 
ultrasound (MRgFUS) can be attributed to either group depending on the clinical indication. 
Clinical treatment of MRgFUS include breast, bone, liver, prostate and brain tumors, uterine 
fibroids, neuropathic pain as well as movement disorders like essential tremor and Parkinson 
tremor (3-6). Regional hyperthermia (RHT) is a well-established non-ablative approach which 
is of clinical value as an adjunct to radio- and/or chemotherapy (7). RHT has been 
demonstrated to improve local control in various locally advanced tumors in a number of 
phase II- and phase III-trials (1). Intratumoral temperature measurements of the applied 
thermal dose have been correlated successfully with clinical endpoints (8-11).  
While accurate thermometry is crucial for hyperthermia treatment, invasive thermometry was 
put into question at an early stage of the development process (12, 13). Potential 
complications such as hemorrhage, infections or neurological complaints, and other 
discomfort were observed along with a low acceptance in patients and physicians (12). 
Driven by this shortcoming, investigators explored surrogates of invasive thermometry. Two 
principle strategies were suggested including minimal-invasive thermometry utilizing specified 
anatomic reference points or tracks in hollow organs such as the rectum, vagina, bladder or 
urethra. Minimal invasive thermometry has demonstrated to be competitive with invasive 
measurements in pelvic tumors (14-16). Alternatively, the traits of magnetic resonance 
imaging (MRI) were put to good use for non-invasive thermography. Because of its spatial 
resolution and anatomic coverage per unit time MRI appears most suitable for non-invasive 
thermometry versus other physical approaches including impedance tomography, 
microwave imaging, computed tomography or ultrasound (16). Since the advent of MR 
thermometry (17, 18), the first decade of development culminated in techniques allowing for 
qualitative temperature assessment in thermal therapies (19-21). The second decade of 
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development advanced the capabilities of MR thermometry towards more robust and 
reliable in vivo applications (22-25). The future target of MR thermometry developments is 
clearly formed around novel methodology and hardware that supports accurate absolute 
temperature readings in vivo with the current developments already pushing into this 
direction (26-31). These efforts are essential to benchmark thermal therapy efficiency, 
understand temperature related biophysical and physiological processes and to use these 
insights for defining and setting new landmarks for diagnostic and therapeutic capabilities. 
Recognizing the technical advances and clinical opportunities of MR thermometry this 
review is an attempt to make the (bio)medical and diagnostic imaging communities aware 
of these developments, so as to engage the interest of potential clinical adopters, to inspire 
collaborations across disciplinary boundaries and to attract basic scientists, engineers, 
hardware professionals, translational researchers, applied scientists and new entrants into the 
field. In the sections that follow, examples of enabling MR thermometry technology and their 
applications are provided. Advances in temperature mapping methodology are discussed 
together with practical considerations and potential pitfalls. Technical obstacles constraining 
temperature measurement accuracy, spatial and temporal resolution of thermal ablation 
and hyperthermia treatments are considered. Established approaches and current trends in 
thermal MR hardware are surveyed together with their practical implications for accurate MR 
thermometry. A concluding section ventures a glance beyond the horizon and explores 
future directions. Of course, MR thermometry is an area of vigorous ongoing research, and 
many potentially valuable developments will receive only brief mention here.  
  
5 
 
Overview of PRF Thermometry 
Numerous MR parameters are sensitive to temperature changes. This includes but is not 
limited to proton density (32), T1 relaxation (33, 34), T2 relaxation (35, 36), apparent water 
diffusion (37, 38) and magnetization transfer (39). The merits and limitations of MR 
thermometry based upon these MR parameters are surveyed in an excellent review (40).  
Proton resonance frequency (PRF) is another viable temperature dependent MR parameter, 
which is commonly applied for in vivo MR thermometry mapping (20, 41, 42). The resonance 
frequency of hydrogen nuclei is proportional to the magnetic field 	 at location . The 
relationship of the applied static magnetic field 
 of an MR scanner to the macroscopic 
magnetic field  inside weakly magnetic materials (|| < 1) like human tissue to the final 
local magnetic field , is governed by the Maxwell equations (42). Assuming a sphere with 
a volume magnetic susceptibility  for macroscopic screening (molecules at a large distance 
of the proton of interest) and a sphere with the screening constant  for microscopic 
screening (hydrogen bound molecule itself and its near neighbors), the relationship between 
 ,   and 
 = 
 can be written as (42): 
 ≅  − 23 + 
 (1) 
 
The electron screening of water   increases linearly in the temperature range of thermal 
ablations and hyperthermia with ! /!# = 0.01	''(/°*, which decreases the chemical 
shift +,''(- = . / − 0 ∙ 102 (41). It can be used to calculate relative temperature changes 
Δ# via phase difference Δ4 measurements to a reference phase 4 / at temperature # / 
(43): 
Δ4 = 4 − 4 / = −5#6#	 − # /		 = −5#6Δ − 23 Δχ + ΔB
	 (2) 
 
With the gyromagnetic ratio 5, echo time #6, Δ = #	 − # /	 and temperature 
induced changes in proton electron screening Δ and magnetic volume susceptibility Δ. 
Neglecting the influence of magnetic volume susceptibilities, the temperature can be 
derived from: 
URL: http://mc.manuscriptcentral.com/thth E-mail: dewhi002@mc.duke.edu
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Δ# = Δ49 ∙ 5 ∙ #6 ∙ 
 (3) 
 
with the proportionality constant 9 = !/!#. Apart from adipose tissue, 9 is relatively 
independent of tissue type and found in the range of 0.009-0.01ppm/°C (44, 45). With the 
characteristics of excellent linearity and sensitivity of the proton electron screening in the 
investigated temperature range and the advantages of phase over magnitude 
measurements with a) robustness towards B1 inhomogeneity and b) the ability to use fast 
imaging techniques like gradient echoes, the PRF method is the most suitable and widely 
used technique for non-invasive MR thermometry in vivo (40).  
  
7 
 
Pitfalls and Practical Solutions 
Notwithstanding the ubiquity and success of PRF thermometry, multiple technical, physical 
and biophysical challenges remain, which need to be addressed. The technical challenges 
include magnetic field drift of the MR magnet over time and spatio-temporal resolution 
constraints. Physical challenges are temperature dependent changes in relative permittivity, 
electric conductivity and magnetic susceptibility as well as field strength dependent 
implications on the imaging techniques used. Biophysical challenges include tissue 
dependent chemical shift, tissue perfusion and diffusion changes. Respiratory motion and 
cardiac activity constitute physiological constraints that govern the accuracy of PRF MR 
thermometry but also dictate the viable window of data acquisition. An overview of some 
relevant parameters influencing the temperature error is outlined in Table I. Equipped with the 
basic methodology of PRF based MR thermometry the sections that follow discuss these 
pitfalls and provide practical solutions for in vivo applications. 
 
Static magnetic field B0 
The static magnetic field may vary over the time course of a thermal therapy. This is in 
particular relevant for the PRF method which is very sensitive to magnetic field changes 
(~0.01ppm/°C in aqueous tissue ) and relies on a phase difference calculation to a reference 
map. Assuming a constant temperature and a magnetic field drift of 0.02 ppm/h would 
generate an error of ±2°C over one hour. Corrections of the field drift can be performed by 
using external reference probes with a known temperature like the water bolus typically 
surrounding the patient in RF hyperthermia treatment (46). Alternatively, lipids are commonly 
employed as a reference since their chemical shift is largely immune to temperature changes 
(19, 21, 47). Internal references like unheated tissue regions (48) or fatty tissue (49) can also be 
used for drift correction. An example of an in vivo PRF map using fatty tissue for correction is 
illustrated in Figure 1a. After suitable regions of adipose tissue have been labeled, phase 
correction is performed fitting linear or higher order functions to the phase information in the 
selected fat regions (49). 
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Chemical Shift 
The temperature dependent chemical shift has a small tissue dependence in the range of 
published values –(0.009-0.01)ppm/°C (except adipose tissue) (44, 45) (Table I), which leads 
to a reasonably small temperature error. In phantom heating experiments, which are 
performed for RF safety testing or evaluation of MR thermometry methods, high temperature 
reading accuracies are desirable. Depending on the phantom the proportionality constant 9 
can exhibit higher deviations from pure water literature values leading to inaccuracies in 
temperature readings. A calibration procedure with accurate fiber tracking and monitoring 
of the temperature evolution at different locations can reduce the maximum temperature 
error significantly, e.g. from ~2.2°C to ~0.2°C (50).  
In contrast, the lipid resonance frequency exhibits only a minor temperature dependent 
chemical shift of –0.00018 ppm/°C ((51), Table I) making it elusive of using the PRF method for 
accurate temperature mapping in fat. For voxels containing both water and fat, where the 
phase is a sum of both signals, temperature errors increase. Solutions are provided with water 
and fat separated thermal (WAFT) MRI using Dixon chemical shift based fat-water separation 
to correct for some of the temperature errors while using the fat signal as an internal 
reference (52). This approach reaches a temperature accuracy as good as -0.09±0.34°C in 
homogeneous phantoms (53). Fat suppression techniques can be employed using spectral 
selective RF pulses or inversion recovery techniques with the evolution time being adjusted 
based upon the T1 relaxation time of fat (54). These techniques are sensitive to 
inhomogeneities in the transmission field which is pronounced at higher magnetic field 
strengths (55). Water selective excitation using spatial-spectral (SPSP) RF pulses is another 
option to suppress lipid signal contributions and to reduce sensitivity to B1 inhomogeneities 
(56-59).  
In general lipid suppression is promising at higher magnetic fields B0 due to a higher chemical 
shift between water and fat (~1000Hz at B0=7.0T). An intriguing approach exploiting this 
characteristic has been demonstrated at 7.0 T using a frequency selective asymmetric spin-
echo based echo planar imaging (EPI) technique (28). This approach employed a slice 
URL: http://mc.manuscriptcentral.com/thth E-mail: dewhi002@mc.duke.edu
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selection gradient reversal methodology for fat suppression. The gradient reversal using 
gradients of differing polarity for excitation and refocusing together with bandwidth-time 
product changes of the radiofrequency pulses allowed imaging of on-resonant species and 
suppression of off-resonant species (28). This approach yielded an in vivo temperature 
stability in the human brain of -0.1±0.3°C (28).  
 
Electromagnetic tissue properties 
Temperature dependent changes in the electromagnetic properties of tissue might have 
various implications. An increasing temperature decreases the relative permittivity (~0.5%/°C 
for water (60)) and increases the electric conductivity (~1.7%/°C for dog muscle (61)) of 
tissue, which both have implications on phase velocity :; in a lossy medium or tissue: 
:; = < 2=> ?<1 + @A>BC + 1D
EF/C
 
(4) 
 
With the absolute permittivity >, the permeability =, the angular frequency A and the 
electrical conductivity . This leads to changes in transmit (B1+) and receive (B1-) phase due 
to alterations in phase propagation speed (Equation 4) (60). While this effect is mostly 
significant in larger heating volumes like in deep regional RF hyperthermia, it can be 
corrected easily utilizing a double echo-method correcting the generated echo time 
dependent temperature coefficient (60). The extension of Equation 3 allows for a simple 
correction of this effect: 
Δ#  = @Δ4G;#6C	 − Δ4G;#6F	B − @Δ4 /#6C	 − Δ4 /#6F	B59
#6C − #6F	  
(5) 
 
with 4 / being a reference unaffected by temperature change (water bolus) or resonance 
frequency shift (fat) in order to compensate for the 
 field drift over time. The temperature 
error due to phase retardation is relatively constant for low and high field MR applications 
(60). 
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In addition to the aforementioned changes in phase velocity, relative permittivity and electric 
conductivity changes might further influence B1+ and B1-. This effect is a consequence of 
direct power losses due to increased electrical conductivity ('HI	JHKK	!LKMNO ∝ ) (60) as 
well as changes in tissue impedance, which determines RF coil loading. Depending on the RF 
coil type and its sensitivity to these changes and the heated volume, this might influence the 
scattering parameters increasing total reflected power and/or coupling in multi-channel 
arrays modifying B1 amplitude and phase distribution. 
The permeability = or magnetic susceptibility  of tissue with the relation = = =
= = =
χ + 1	 
is also temperature dependent and influences phase velocity (Equation 4). However the 
temperature increase of the permeability is rather low (3 × 10ER%/°* for pure water) as 
compared to temperature induced changes in permittivity and conductivity and hence can 
be neglected (60). 
 
Magnetic susceptibility 
Temperature dependent susceptibility might compromise the local magnetic field 
 and the 
surrounding macroscopic field   (43). This is a major drawback of the PRF method for 
accurate MR thermometry in and around fatty tissues (43, 62). While the temperature 
dependent magnetic susceptibility of water based tissue is rather small with ! /!# =
0.0016	''(/°* (muscle tissue (42)) as compared to the changes in the electron screening 
constant, the susceptibility of fat !//!# = 0.0039 − 0.0076	''(/°* (breast fat (43)) is close to 
the proton electron screening of water (43) (Table I). High fat content tissue consequently 
hampers temperature reading accuracy. Simulations in breast tissue demonstrated a 
maximum error of -8.6°C for an absolute temperature change of ∆T=30°C in HIFU ablation 
(43). Assuming more realistic temperature dependent susceptibilities of fat (63), this would 
result in a standard deviation of ~1°C for a ∆T=5°C in an hyperthermia application. 
The temperature error >W based on magnetic susceptibility can be estimated given the 
following equation (43): 
>W = − 19 Δ
Δ# − 23 ΔΔ#	 (6) 
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together with published values of temperature dependent magnetic susceptibilities of tissue 
(Table I). 
To mitigate this error, hybrid methods combining the PRF shift and other temperature 
dependent MR parameters like apparent diffusion coefficient (64) or T1 (34, 65, 66) are 
investigated. Multi gradient echoes with variable flip angles allow using the magnitude 
information for T1 mapping and temperature related T1 changes in lipids and the phase 
information for PRF thermometry in aqueous tissue (65, 66). While such hybrid methods are 
potentially appealing, its propensity to B1 changes as well as temperature dependent M0 and 
T2* changes reduce T1 mapping accuracy. The choice of echo time TE is furthermore a 
compromise between T1 mapping accuracy (short TEs preferable) and PRF based MR 
thermometry (TE=T2* for maximum SNR∆φ (67)) (65). Adding a high-bandwidth multi-echo 
readout allows for some improvement in mean PRF precision up to ±1.3°C and T1 precision of 
±3.5% (34).  
A recently proposed MR method based on intermolecular multiple quantum coherences is 
insensitive to macroscopic field changes (26). With this approach an average error of 0.6°C 
for relative temperature measurements and 1.7°C for absolute temperature measurements 
was achieved (29, 30). While its imaging speed and SNR limitations currently prevent rapid 
temperature monitoring in thermal ablation, its potential for MR thermometry in hyperthermia 
therapies of several minutes heating time is intriguing.  
 
Perfusion 
Perfusion based phase changes unrelated to temperature changes may be misinterpreted 
and might over- or underestimate measured temperatures (21, 49). As an example, the 
severe over- and underestimation of PRF readings due to perfusion changes in muscle and 
tumour tissue is demonstrated in Figure 1b. In general alterations in the concentration of 
oxygen, which in its pure form is paramagnetic and diamagnetic when bound to hemoglobin 
(oxyhemoglobin) affect the local static magnetic field (49, 68). The direction of perfusion 
influences these local field changes (69). Various MR techniques exist, that allow to measure 
perfusion using first pass bolus exogenous contrasts. This includes dynamic susceptibility 
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contrast-enhanced (DSC) or dynamic contrast-enhanced (DCE) perfusion weighted MRI. 
Endogenous contrast based perfusion MRI techniques involve arterial spin labelling 
techniques (70, 71) and intra-voxel incoherent motion approaches (72). If these corrections 
need to or can be employed depends on the thermal therapy with its boundary conditions 
on temporal resolution and expected perfusion changes in the region of interest.  
 
Motion 
The PRF method is a relative temperature measurement relying on phase difference 
calculations versus a reference measurement. Any intra-scan motion leading to 
misregistration with the reference phase image results in temperature errors. These errors 
might be caused by respiratory, cardiac, peristaltic or bulk motion with standard deviations of 
>±10°C even without any application of heat (25, 73). Structural changes of the treatment 
area due to tissue coagulation during an ablation procedure (40) can as well be 
misinterpreted as temperature changes. Thermal therapy duration typically exceeds clinical 
acceptable breathold times of 10-20s or the duration of a cardiac cycle (~60 beats per 
minute), necessitating respiratory/cardiac gated temperature mapping (74, 75) or the use of 
navigator echoes for motion correction (76). The so called multi-baseline methods acquire 
not only one but a whole library of reference images during the respiratory/cardiac cycle. 
This library is used to link the phase measured during thermal therapy to the correct reference 
image by means of an acquired navigator echo (22), non-similarity coefficients (77) or 
intercorrelation coefficients (78, 79). While robust to periodic motion, reference or baseline 
methods are prone to irregular physiological motion such as arrhythmia.  
Global magnetic field changes due to motion induced B0-drift or local magnetic field 
changes due to magnetic susceptibilities constitute another source for errors. Addressing the 
issue of irregular physiological motion is the forte of referenceless PRF methods which 
eliminate the use of a temporal reference via estimation of the background phase (23). 
Based on a region unaffected by thermal changes or a region unaffected by a thermal 
phase shift (fat) around the region of interest for thermal monitoring, the background phase 
information is fitted by a polynomial function (23, 49, 80, 81). Using a reweighted regression 
13 
 
even regions affected by thermal changes can be used to estimate the background phase 
(82). Since referenceless methods alone are sensitive to phase variations at organ interfaces 
due to susceptibility changes, combined referenceless multi-baseline methods have been 
suggested improving robustness (83). In addition, these methods hold the promise to track 
motion like organ deformation using intrinsic vasculature as landmarks (84). Referenceless 
methods have been successfully applied in vivo (85, 86). 
 
Implants 
A source of strong susceptibility artefacts and even signal voids are electrically conductive 
implants including stents, clips, sleeves, small osteosynthetic components etc, which are no 
contraindication for RF-hyperthermia, but disturb MRI. Even if the targeted region for the 
thermal therapy treatment is located sufficiently far away from these artefacts, near-implant 
temperature measurements might nevertheless be crucial for safety assessment. For the high 
powers applied in RF hyperthermia treatment significant temperature elevations can occur 
around electrically conductive implants due to electromagnetic induction. To avoid tissue 
damage these temperature elevations can be estimated using a fast analytical approach 
which has been demonstrated for coronary stents and which can be easily incorporated in 
hyperthermia treatment planning software (87). However for the majority of implants 
available, these generalized and rapid estimations are still missing, rendering online MR 
thermometry of near-implant temperatures necessary. Figure 2a, which displays magnitude 
and phase images acquired in and around an electrically conductive coronary stent at 7.0T, 
exemplifies the difficulties determining reliable temperature maps. The increasing number of 
phase wraps at prolonged TE for a constant spatial resolution reduces the range of sampled 
phase values and increases the risk of voxel misregistration, all of which reduces the fidelity of 
PRF MR thermometry. Even at shorter echo times, the calculated temperature maps display 
artefacts inside the stent as well as in regions in close vicinity to the stent. These artefacts are 
less pronounced in an imaging plane positioned few millimetres away from the stent (Figure 
2b). This makes the evaluation of very local temperature challenging. However with prior 
knowledge of the expected EM induction effects and thermal distributions, accuracies of MR 
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thermometry using the PRF method correlate fairly well (~1°C) with fiber optic temperature 
probes (Figure 2c) (87, 88). Unlike the PRF method, T1 based MR thermometry methods avoid 
the strong sensitivity towards susceptibility differences and hence provide superior fidelity 
(<1°C) over PRF if benchmarked against fiber optic temperature measurements (33, 89, 90). 
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Implications of thermal therapy hardware 
The choice of hardware to induce temperature changes in tissue has significant implications 
on the feasibility, accuracy and/or spatial and temporal resolution of MR thermometry. In this 
chapter implications of invasive and non-invasive devices utilized for thermal therapies are 
discussed. 
 
Interstitial devices 
For interstitial and endocavitary hyperthermia treatments or ablation, devices are implanted 
in the target region e.g. within the tumor. Typically microwave or RF antennas, US transducers 
or laser fibers are utilized (91, 92). While laser fibers are relatively artefact free, RF ablative 
devices disturb the static magnetic field B0 and cause susceptibility artefacts along with 
transmission and reception field perturbations making accurate thermal dose assessment in 
close vicinity to the device elusive. PRF based methods can provide a qualitative heating 
assessment around metal, however fail to provide accurate quantitative temperature data 
(93). Here T1 based temperature mapping is more promising but still suffers from tradeoffs in 
speed and accuracy (33, 94). Imaging methods exist, that correct for slice-selection and 
frequency encoding distortions like slice encoding for metal artifact correction (SEMAC) (95) 
or multi-acquisition variable-resonance image combination (MAVRIC) (96). Yet, translation 
towards reasonable spatio-temporally resolved temperature maps is challenging. In general 
interstitial devices need to be investigated for possible MR imaging artefacts, which might 
falsify MR thermometry results. 
 
MR guided hybrid systems 
Various non-invasive ablation and hyperthermia methods exist, which are free of the 
aforementioned challenges for monitoring of interstitial devices. Magnetic resonance guided 
focused ultrasound (MRgFUS or MRgHIFU) utilizes acoustic energy directed at the target 
region (97). While MRI is a valuable tool for treatment planning, since cancerous tissue can be 
visualized, it is furthermore used to guide the ultrasound beam in conjunction with adjusting 
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the power levels by means of MR thermometry. In this procedure birdcage RF coils or large 
volume body RF coils are commonly used for signal transmission and reception for PRF or T1 
mapping based MR thermometry (97). Temperature mapping accuracy is a tradeoff 
between spatial and temporal resolution and highly dependent on the signal-to-noise ratio 
(SNR) available either for the MR thermometry method itself or for additional correction 
methods (B1 mapping, perfusion measurements etc.). Local multichannel receive RF coils can 
enhance SNR significantly (98), which can be used for high spatial resolution MRI or parallel 
imaging techniques that accelerate image acquisition (99-102). While these multi-channel 
receive RF coils are clinical practice in diagnostic MRI applications, integration in a MRgFUS 
treatment device is challenging due to possible interferences of the ultrasound beam and 
the metallic/conducting structures of the RF coil array. To relax this issue customized phased 
array RF coils can be applied, which improve SNR as well as image acquisition speed (103). 
The construction of these arrays however is a compromise in RF coil design. The conductive 
path of the RF coil elements needs to be built “around” the ultrasound transducers or 
positioned behind the water bath required for coupling of the acoustic energy, preventing 
higher SNR to be achieved (103).  
A similar challenge to gain highest possible SNR and parallel imaging performance for high 
spatial and temporal resolution MR temperature mapping is present in hybrid regional RF 
hyperthermia systems (Figure 3). These systems utilize electromagnetic fields in the 
radiofrequency range in order to focus power absorption to the target region (1, 24, 104-107). 
Here the same problem arises with an integration of multichannel receive arrays. The 
electrically conductive paths of the receive coils positioned closely to the body may 
influence the E-field distribution produced by the RF applicator for targeted hyperthermia. 
Other challenges are space constraints due to the magnet bore size and coupling of the RF 
hyperthermia hardware typically driven at high signal amplitudes (>100V) in continuous wave 
transmission while the receive architecture is designed to handle NMR signals in the range of 
10-6V (108). The latter is a potential source of imaging artefacts which needs to be addressed 
by additional filters or pre-amplifier design integrated in the hardware architecture of the MR 
system (Figure 3) (108). These errors may also be attributed to the hyperthermia treatment 
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frequency (100MHz) being rather close to the MR transmission frequency (64MHz), while other 
approaches using higher transmission frequencies (434MHz) didn’t observe imaging artifacts. 
It should be noted that the latter setups used lower power levels (2x270W@434MHz (109) as 
compared to 900-1600W@100MHz (108)). Since image artifacts depend strongly on both 
transmitting and receiving RF hardware, it is therefore crucial to investigate and eliminate 
possible interferences in order to acquire reliable temperature information.  
 
Integrated systems or thermal MR 
Another approach for improved MR thermometry, which is currently under development, is 
an integrated system designated as thermal MR using the power amplifier and RF antennas 
for both MRI and targeted RF hyperthermia (31) (Figure 3). This is in particular attractive at 
ultra-high magnetic fields (B0≥7.0T, f≥298MHz), where multi-channel transmit hardware 
technology is available. Today, even clinical high field (B0=3.0T, f=128MHz) scanners are 
empowered with the ability to modify amplitude and phase of up to eight independent RF 
power amplifiers (110). In contrast to RF hyperthermia using continuous wave (CW) 
transmission, MR power amplifiers are designed to provide narrow band high peak power 
pulses. The average delivered power is determined by the RF pulse shape together with the 
applied repetition time and limited by the duty cycle and long term stability of the RFPA. At 
7.0T with an integrated 8x1kW RFPA and ~30% RF cable losses to the RF coil plug, this would 
result in an average power of 560 W at a duty cycle of 10% (31). While UHF-MR systems 
equipped with 8x2kW or even 16x2kW are expected to become available soon, this would 
allow for an average RF power of 1120 W and 2240 W respectively, assuming similar duty 
cycle and RF losses. The advantage of a pulsed RFPA used for RF hyperthermia application 
and MR thermometry is the ability to modify the imaging technique in order to perform RF 
hyperthermia and MRI simultaneously at the same frequency. This approach exhibits the merit 
of an artefact free operation without the need for additional hardware modifications (31). In 
order to reach sufficient RF power deposition levels in tissue high power RF pulses used for 
imaging can be applied, off-resonance pulses can be incorporated in the imaging 
technique or a combination of the two. The advantage of using UHF-MR for temperature 
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monitoring is yet to be investigated and benchmarked against lower field systems. In addition 
to SNR gains and phase noise reduction at UHF (111-113), improvements are expected by 
using local multi-channel receive arrays for MR thermometry which demonstrated major SNR 
benefits over the use of the traditional RF body coil approach and are clinical routine 
(B0 ≤ 3.0T) (98, 114-116).  
Ideal surface current pattern simulations that resemble RF receivers demonstrated, that curl-
free components dominate at 7.0T as compared to divergence-free components that 
dominate at lower fields (117, 118). This justifies the use of birdcage type RF coils for 
transmission and loop RF coils for reception at lower fields (B0≤3.0T), while dipole antennas are 
well suited as transmit/receive elements for UHF MRI at B0≥7.0T (31, 119-121) and above (122). 
SNR maps (123, 124) of a 16-channel bow tie dipole antenna array (121) and a 32-channel 
loop RF coil array (125) tailored for cardiac imaging at 7.0T emphasize this, showing higher 
SNR values acquired with a diploe antenna array versus the loop coil array (Figure 4) (121). 
The usage of dipole or “dipole-like” antennas as a targeted RF heating device is very well 
recognized by the hyperthermia community (104, 126-128). Recent reports demonstrated for 
the first time the feasibility of an integrated device that supports diagnostic MR, MR 
thermometry and localized RF hyperthermia using bow tie electric dipoles immersed in high 
permittivity dielectric (31). In addition to the discussed potential SNR gains for MR 
thermometry, the use of a higher RF hyperthermia frequency (f=298MHz) as compared to 
current clinically applied regional hyperthermia frequencies (f=70-100MHz) helps to create a 
smaller temperature hotspot. For body applications this allows to reduce the relevant 
temperature monitoring volume. This approach helps to preserve imaging time, reduce 
magnetic susceptibility artefacts created by heating of unwanted tissue regions or to use 
referenceless PRF methods typically applied for HIFU treatment (81). On the contrary regional 
RF hyperthermia could be as well performed in an integrated system at 3.0T with a proton 
resonance frequency of 128MHz. Current 3.0T MR systems are equipped with 32kW peak 
power amplifiers, driven at 10% duty cycle this would allow for 3.2kW average power which is 
double the value used in current hybrid systems with 1.6kW (108). Some research 3.0T 
scanners are even equipped with a multi-channel transmission system allowing for 8x8kW 
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(110). However MR imaging performance of electric dipole antennas at 3.0T still needs to be 
investigated.  
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Clinical studies 
PRF thermometry has been applied successfully in clinical thermal therapies ranging from 
mild-hyperthermia treatment to thermal ablation. In MRgFUS treatment of uterine fibroids PRF 
thermometry is an important marker to adjust sonication power to ensure coagulation at the 
target and to monitor thermal dose (129, 130). In breast cancer treatment, using the PRF 
method alone evoked difficulties in the localization of the thermal hotspot due to fat regions 
(131). Here hybrid methods using additional T1 contrast for temperature readings in fat 
reduced the PRF error significantly (34). Treating liver cancer with MRgFUS is hindered by the 
ribcage interfering with an efficient focusing of the acoustic energy and respiratory motion. 
To counter motion artefacts in PRF thermometry of the liver, respiratory gating, breathing 
control or fast 2D spoiled gradient echo sequences with acquisition times of ~3s and spatial 
resolutions at ~1mm (132-134) were employed. While these clinical reports are promising, 
more validation studies are essential to benchmark MR temperature reading accuracy 
against reference measurements derived from fiber optic temperature probes (Figure 1b). 
This research strives to eventually predict accurate necrosed tumor volumes based on 
thermal dose calculations. 
MR guided RF hyperthermia on the other hand has been used successfully to treat human 
high grade sarcoma of the extremities or pelvis (105, 106, 135) and recurrent rectal 
carcinoma (49). Lengthy treatment times of >1h evoked magnetic field drifts which were 
corrected by using external probes, the water bolus surrounding the patient or anatomical fat 
references with polynomial background phase fitting (46, 49, 106, 135). With this correction in 
place the standard deviation of PRF thermometry to fiber optic measurements was found to 
be ~1°C (Figure 1b). Temporal resolution constraints are more relaxed for RF hyperthermia 
treatments where tissue temperatures ∆T<10°C are applied for several minutes in contrast to 
MRgFUS ablation with temperatures ∆T>30°C reached in several seconds. On the other hand 
perfusion effects and their influence on temperature readings are pronounced in RF 
hyperthermia treatment in particular at treatment frequencies of 100Mhz or less due to an 
overall high volume of temperature increase and the associated thermoregulation. An 
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increase in perfusion and consequently diamagnetic oxyhemoglobin reduces the PRF and 
overestimates temperatures (Figure 1b) (49), which needs to be corrected. 
Conclusions 
This review aims at encouraging pioneers and early adopters interested in pursuing MR 
thermometry in basic and clinical research. Multiple clinical studies demonstrated the 
maturity of MR thermometry for in vivo applications (49, 106, 129, 130). The sensitivity of the 
PRF method to motion, perfusion and susceptibility changes, as well as the inability to 
measure temperatures in fatty tissue, are remaining challenges to improve accuracy and 
expand its clinical potential. Here promising solutions have been provided during the last 
years that overcome many of these obstacles and have been applied successfully in vivo 
(25, 34, 65, 66). The clinical application will ultimately dictate the MR methodologies used to 
monitor thermal therapies. While the time window for thermal ablations requires real-time 
monitoring, hyperthermia treatments with rather long treatment durations and smaller 
temperature increases are less constrained on the image acquisition side. New hardware 
solutions, in particular integrated MR systems at ultrahigh fields to control and monitor RF 
induced heating are promising to fully exploit the merits of state-of-the-art MR thermometry 
(31). The need for accurate MR thermometry will likely pave the way for further advances in 
MR methodology, MR technology and MR systems design with the ultimate goal of 
quantitative temperature mapping (25-28). The access to reliable temperature information 
will have major implications on basic and clinical research: enhancing the efficiency of 
thermal therapies, enabling better understanding of temperature related biological 
processes, boosting targeted drug delivery (136) and heat activated gene therapy 
monitoring (137) or improving safety and diagnostic capabilities of MRI applications while 
providing more realistic power limitations (138, 139).   
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Figure & Table Captions 
Table I: Overview of relevant parameters for temperature error estimations: static magnetic 
field 
, chemical shift +, permittivity >, electric conductivity , permeability = and magnetic 
volume susceptibility . The time dependent changes in 
 are based on a magnetic field 
drift of the magnet over time. Electromagnetic property (>, , =) changes with temperature 
influence phase velocity of the RF pulse, B1 and RF coil loading introducing additional echo 
time dependent phase changes. Please note that magnetic susceptibility might change as 
well due to perfusion and diffusion changes. 
 
Figure 1: a-c) Clinical example of MR guided (B0 = 1.5 T) RF hyperthermia treatment of 
recurrent rectal carcinoma. a) T1-weighted anatomical reference. b) Uncorrected 
temperature distribution together with the contours delineating anatomical fat regions used 
for phase drift correction. c) Corrected temperature distribution together with the contours 
delineating the tumor. For PRF thermometry spoiled gradient echo images were acquired 
after an RF heating duration of 57 minutes and temperature was calculated with regards to a 
reference phase map prior to the thermal therapy (49). d-f) Influence of perfusion changes 
on PRF thermometry in comparison to fiber optic temperature sensor readings in RF 
hyperthermia treatment of soft tissue sarcoma of the lower extremities. d) T1-weighted 
anatomical reference and location of the fiber optic temperature reading track. e) PRF 
thermometry showing the temperature hotspot. For PRF thermometry drift corrected phase 
difference of spoiled gradient echo images towards a reference prior to the thermal 
treatment was evaluated (106). f) Comparison of PRF thermometry and fiber optic 
thermometry. Sincere under- and overestimation in PRF thermometry in the presence of 
perfusion decrease and increase can be seen. In the muscle reactive perfusion increases 
during RF hyperthermia (on the left side away from the tip). In tumours no or low reactive 
perfusion is expected, showing very good accuracy (<1°C) between fiber optic 
measurements and PRF thermometry. At the tumor margin perfusion declines (at the tip of the 
catheter), probably caused by the adjacent hyperperfused muscle (steal effect).  
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Figure 2: a) Echo time dependent magnitude and phase images at 7.0T of a coronary stent 
placed in an agar phantom. Please note how signal voids and phase wraps evolve with 
prolonged echo times. b) MR photograph of a coronary stent (left) used in RF heating 
experiments. PRF thermometry through the plane of the stent (middle) and in the plane 
slightly above the stent (right) using a double echo method (TE1 and TE2), where imaging 
artefacts are reduced. c) Comparison of MR thermometry and fiber optic thermometry in 
regions of the stent and surface regions of a homogeneous phantom (87). 
 
Figure 3: Schematic of a hybrid MR guided RF hyperthermia system (1) and an integrated 
system presented recently (31). While the hybrid system requires two separate RF amplifiers 
and control units plus additional hardware filters that need to be incorporated into the 
standard MR hardware, the integrated system utilizes the proton excitation frequency of the 
MR system as well as its pulsed power amplifier and control unit to perform RF induced 
heating. Only transmit receive switches are added to the integrated system, which can be 
done externally as an integral part of the applicator and does not involve changes in the 
standard MR architecture itself (31). 
 
Figure 4: SNR comparison of a 16-channel bow tie dipole array (121) and a 32-channel loop 
coil array (125) for cardiac imaging at 7.0 T. A 2D CiNE FLASH of a short axis view (SAX) 
(1.1x1.1x2.5) mm² and its corresponding SNR map (123, 124) is displayed for a GRAPPA 
reduction factor R=2. The 16-channel bow tie dipole array shows higher mean SNR values as 
compared to the 32-channel loop coil indicating its feasibility for MRI at UHF (B0 = 7.0 T) (121). 
The excellent image quality obtained from using dipole antennas for MRI demonstrates the 
rationale of these elements to be used for an integrated system. 
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 Parameter Value 
Static magnetic field / field drift 0.02 ppm/h (88) 
Chemical shift / pure water -0.01 ppm/°C (41) 
  tissue (except fat) -(0.009-0.01) ppm/°C (45) 
  fat -0.00018 ppm/°C (51) 
Permittivity / water -0.5 %/°C (60) 
Electrical conductivity 	
/ dog muscle 1.7 %/°C (61) 
Permeability / water 3·10-7 %/°C (60) 
Magnetic susceptibility / pure water 0.0026 ppm/°C (30-45°C) (42)  
  muscle 0.0016 ppm/°C (30-45°C (42) 
  breast fat 0.0039-0.0076 ppm/°C (63) 
  air -0.002 ppm/°C (68) 
 
Table I: Overview of relevant parameters for temperature error estimations: static magnetic field 
, chemical shift , permittivity , electric conductivity 	
, permeability  and magnetic volume 
susceptibility . The time dependent changes in  are based on a magnetic field drift of the 
magnet over time. Electromagnetic property (, 	, ) changes with temperature influence phase 
velocity of the RF pulse, B1 and RF coil loading introducing additional echo time dependent 
phase changes. Please note that magnetic susceptibility might change as well due to perfusion 
and diffusion changes. 
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Figure 1: a-c) Clinical example of MR guided (B0 = 1.5 T) RF hyperthermia treatment of recurrent rectal 
carcinoma. a) T1-weighted anatomical reference. b) Uncorrected temperature distribution together with the 
contours delineating anatomical fat regions used for phase drift correction. c) Corrected temperature 
distribution together with the contours delineating the tumor. For PRF thermometry spoiled gradient echo 
images were acquired after an RF heating duration of 57 minutes and temperature was calculated with 
regards to a reference phase map prior to the thermal therapy (48). d-f) Influence of perfusion changes on 
PRF thermometry in comparison to fiber optic temperature sensor readings in RF hyperthermia treatment of 
soft tissue sarcoma of the lower extremities. d) T1-weighted anatomical reference and location of the fiber 
optic temperature reading track. e) PRF thermometry showing the temperature hotspot. For PRF 
thermometry drift corrected phase difference of spoiled gradient echo images towards a reference prior to 
the thermal treatment was evaluated (105). f) Comparison of PRF thermometry and fiber optic 
thermometry. Sincere under- and overestimation in PRF thermometry in the presence of perfusion decrease 
and increase can be seen. In the muscle reactive perfusion increases during RF hyperthermia (on the left 
side away from the tip). In tumours no or low reactive perfusion is expected, showing very good accuracy 
(<1°C) between fiber optic measurements and PRF thermometry. At the tumor margin perfusion declines (at 
the tip of the catheter), probably caused by the adjacent hyperperfused muscle (steal effect).  
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Figure 2: a) Echo time dependent magnitude and phase images at 7.0T of a coronary stent placed in an 
agar phantom. Please note how signal voids and phase wraps evolve with prolonged echo times. b) MR 
photograph of a coronary stent (left) used in RF heating experiments. PRF thermometry through the plane 
of the stent (middle) and in the plane slightly above the stent (right) using a double echo method (TE1 and 
TE2), where imaging artefacts are reduced. c) Comparison of MR thermometry and fiber optic thermometry 
in regions of the stent and surface regions of a homogeneous phantom (87).  
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Figure 3: Schematic of a hybrid MR guided RF hyperthermia system (1) and an integrated system 
presented recently (31). While the hybrid system requires two separate RF amplifiers and control units plus 
additional hardware filters that need to be incorporated into the standard MR hardware, the integrated 
system utilizes the proton excitation frequency of the MR system as well as its pulsed power amplifier and 
control unit to perform RF induced heating. Only transmit receive switches are added to the integrated 
system, which can be done externally as an integral part of the applicator and does not involve changes in 
the standard MR architecture itself (31).  
178x190mm (96 x 96 DPI)  
 
 
For Peer Review Only
  
 
 
Figure 4: SNR comparison of a 16-channel bow tie dipole array (120) and a 32-channel loop coil array 
(124) for cardiac imaging at 7.0 T. A 2D CiNE FLASH of a short axis view (SAX) (1.1x1.1x2.5) mm² and its 
corresponding SNR map (122, 123) is displayed for a GRAPPA reduction factor R=2. The 16-channel bow tie 
dipole array shows higher mean SNR values as compared to the 32-channel loop coil indicating its feasibility 
for MRI at UHF (B0 = 7.0 T) (120). The excellent image quality obtained from using dipole antennas for MRI 
demonstrates the rationale of these elements to be used for an integrated system.  
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